Mechanisms of Phytonutrient Modulation of Cyclooxygenase-2 (COX-2) and Inflammation Related to Cancer

References

• Horneber M, Bueschel G, Dennert G, Less D, Ritter E, et al.: How many cancer patients use complementary and alternative medicine: a systematic review and metaanalysis. Integrative Cancer Therapies 11, 187–203, 2012. doi:10.1177/1534735411423920.
   PubMed Web of Science ®Google Scholar
• Bishop FL, Prescott P, Chan YK, Saville J, von Elm E, et al.: Prevalence of complementary medicine use in pediatric cancer: a systematic review. Pediatrics 125, 768–776, 2010. doi:10.1542/peds.2009-1775.
   PubMed Web of Science ®Google Scholar
• Perlman A, Lontok O, Huhmann M, Parrott JS, Simmons LA, et al.: Prevalence and correlates of postdiagnosis initiation of complementary and alternative medicine among patients at a comprehensive cancer center. J Oncol Pract 9, 34–41, 2013. doi:10.1200/JOP.2012.000634.
   PubMedGoogle Scholar
• Rayburn ER, Ezell SJ, and Zhang R: Anti-inflammatory agents for cancer therapy. Mol Cell Pharmacol 1, 29–43, 2009. doi:10.4255/mcpharmacol.09.05.
   PubMedGoogle Scholar
• Bismark RS, Chen HB, Dy GK, Gage-Bouchard EA, and Mahoney MC: Complementary and alternative medicine use among patients with thoracic malignancies. Support Care Cancer 22, 1857–1866, 2014. doi:10.1007/s00520-014-2144-0.
   PubMed Web of Science ®Google Scholar
• Sing MF, Yang WS, Gao S, Gao J, and Xiang YB: Epidemiological studies of the association between tea drinking and primary liver cancer: a meta-analysis. Eur J Cancer Prev 20, 157–165, 2011. doi:10.1097/CEJ.0b013e3283447497.
   PubMed Web of Science ®Google Scholar
• Tang NP, Zhou B, Wang B, Yu RB, and Ma J: Flavonoids intake and risk of lung cancer: a meta-analysis. Jpn J Clin Oncol 39, 352–359, 2009. doi:10.1093/jjco/hyp028.
   PubMed Web of Science ®Google Scholar
• Dong JY and Qin LQ: Soy isoflavones consumption and risk of breast cancer incidence or recurrence: a meta-analysis of prospective studies. Breast Cancer Res Treat 125, 315–323, 2011. doi:10.1007/s10549-010-1270-8.
   PubMed Web of Science ®Google Scholar
• Hwang YW, Kim SY, Jee SH, Kim YN, and Nam CM: Soy food consumption and risk of prostate cancer: a meta-analysis of observational studies. Nutr Cancer 61, 598–606, 2009. doi:10.1080/01635580902825639.
   PubMed Web of Science ®Google Scholar
• Sun CL, Yuan JM, Koh WP, and Yu MC: Green tea, black tea and breast cancer risk: a meta-analysis of epidemiological studies. Carcinogenesis 27, 1310–1315, 2006. doi:10.1093/carcin/bgi276.
   PubMed Web of Science ®Google Scholar
• Seely D, Mills EJ, Wu P, Verma S, and Guyatt GH: The effects of green tea consumption on incidence of breast cancer and recurrence of breast cancer: a systematic review and meta-analysis. Integr Cancer Ther 4, 144–155, 2005. doi:10.1177/1534735405276420.
   PubMedGoogle Scholar
• Nagle CM, Olsen CM, Bain CJ, Whiteman DC, Green AC, et al.: Tea consumption and risk of ovarian cancer. Cancer Causes Control 21, 1485–1491, 2010. doi:10.1007/s10552-010-9577-7.
   PubMed Web of Science ®Google Scholar
• Butler LM and Wu AH: Green and black tea in relation to gynecologic cancers. Mol Nutr Food Res 55, 931–940, 2011. doi:10.1002/mnfr.201100058.
   PubMed Web of Science ®Google Scholar
• Boehm K, Borrelli F, Ernst E, Habacher G, Hung SK, et al.: Green tea (Camellia sinensis) for the prevention of cancer. Cochrane Database Syst Rev CD005004, 2009. doi:10.1002/14651858.CD005004.pub2.
   PubMed Web of Science ®Google Scholar
• Zheng J, Yang B, Huang T, Yu Y, Yang J, et al.: Green tea and black tea consumption and prostate cancer risk: an exploratory meta-analysis of observational studies. Nutr Cancer 63, 663–672, 2011. doi:10.1080/01635581.2011.570895.
   PubMed Web of Science ®Google Scholar
• Kang H, Rha SY, Oh KW, and Nam CM: Green tea consumption and stomach cancer risk: a meta-analysis. Epidemiol Health 32, e2010001, 2010. doi:10.4178/epih/e2010001.
   PubMedGoogle Scholar
• Tang N, Wu Y, Zhou B, Wang B, and Yu R: Green tea, black tea consumption and risk of lung cancer: a meta-analysis. Lung Cancer 65, 274–283, 2009. doi:10.1016/j.lungcan.2008.12.002.
   PubMed Web of Science ®Google Scholar
• Fritz H, Seely D, Kennedy DA, Fernandes R, Cooley K, et al.: Green tea and lung cancer: a systematic review. Integr Cancer Ther 12, 7–24, 2013. doi:10.1177/1534735412442378.
   PubMed Web of Science ®Google Scholar
• Dai QY, He YY, Ho CT, Wang J, Wang SJ, et al.: Effect of interaction of epigallocatechin gallate and flavonols on color alteration of simulative green tea infusion after thermal treatment. J Food Sci Technol-Mysore 54, 2919–2928, 2017. doi:10.1007/s13197-017-2730-5.
   Web of Science ®Google Scholar
• Deandrea S, Foschi R, Galeone C, La Vecchia C, Negri E, et al.: Is temperature an effect modifier of the association between green tea intake and gastric cancer risk? Eur J Cancer Prev 19, 18–22, 2010. doi:10.1097/CEJ.0b013e328330eb1a.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Li N, Zhuang W, Liu G, Wu T, et al.: Green tea and gastric cancer risk: meta-analysis of epidemiologic studies. Asia Pac J Clin Nutr 17, 159–165, 2008.
   PubMed Web of Science ®Google Scholar
• Myung SK, Bae WK, Oh SM, Kim Y, Ju W, et al.: Green tea consumption and risk of stomach cancer: a meta-analysis of epidemiologic studies. Int J Cancer 124, 670–677, 2009. doi:10.1002/ijc.23880.
   PubMed Web of Science ®Google Scholar
• Braem MG, Onland-Moret NC, Schouten LJ, Tjonneland A, Hansen L, et al.: Coffee and tea consumption and the risk of ovarian cancer: a prospective cohort study and updated meta-analysis. Am J Clin Nutr 95, 1172–1181, 2012. doi:10.3945/ajcn.111.026393.
   PubMed Web of Science ®Google Scholar
• Zhou B, Yang L, Wang L, Shi Y, Zhu H, et al.: The association of tea consumption with ovarian cancer risk: a metaanalysis. Am J Obstet Gynecol 197, 594.e1–594.e6, 2007. doi:10.1016/j.ajog.2007.05.027.
   PubMed Web of Science ®Google Scholar
• Steevens J, Schouten LJ, Verhage BA, Goldbohm RA, and van den Brandt PA: Tea and coffee drinking and ovarian cancer risk: results from the Netherlands Cohort Study and a meta-analysis. Br J Cancer 97, 1291–1294, 2007. doi:10.1038/sj.bjc.6604008.
   PubMed Web of Science ®Google Scholar
• Sun CL, Yuan JM, Koh WP, and Yu MC: Green tea, black tea and colorectal cancer risk: a meta-analysis of epidemiologic studies. Carcinogenesis 27, 1301–1309, 2006. doi:10.1093/carcin/bgl024.
   PubMed Web of Science ®Google Scholar
• Baell J and Walters MA: Chemistry: chemical con artists foil drug discovery. Nature 513, 481–483, 2014. doi:10.1038/513481a.
   PubMed Web of Science ®Google Scholar
• Nelson KM, Dahlin JL, Bisson J, Graham J, Pauli GF, et al.: The essential medicinal chemistry of curcumin. J Med Chem 60, 1620–1637, 2017. doi:10.1021/acs.jmedchem.6b00975.
   PubMed Web of Science ®Google Scholar
• Nelson KM, Dahlin JL, Bisson J, Graham J, Pauli GF, et al.: Curcumin may (not) defy science. Acs Med Chem Lett 8, 467–470, 2017. doi:10.1021/acsmedchemlett.7b00139.
   PubMed Web of Science ®Google Scholar
• Kim KB, Nam YA, Kim HS, Hayes AW, and Lee BM: alpha-Linolenic acid: nutraceutical, pharmacological and toxicological evaluation. Food Chem Toxicol 70, 163–178, 2014. doi:10.1016/j.fct.2014.05.009.
   PubMed Web of Science ®Google Scholar
• Smyth EM, Grosser T, Wang M, Yu Y, and FitzGerald GA: Prostanoids in health and disease. J Lipid Res 50 (Suppl), S423–S428, 2009. doi:10.1194/jlr.R800094-JLR200.
   PubMed Web of Science ®Google Scholar
• Sheng H, Shao J, Washington MK, and DuBois RN: Prostaglandin E2 increases growth and motility of colorectal carcinoma cells. J Biol Chem 276, 18075–18081, 2001. doi:10.1074/jbc.M009689200.
   PubMed Web of Science ®Google Scholar
• Ben-Av P, Crofford LJ, Wilder RL, and Hla T: Induction of vascular endothelial growth factor expression in synovial fibroblasts by prostaglandin E and interleukin-1: a potential mechanism for inflammatory angiogenesis. FEBS Lett 372, 83–87, 1995.
   PubMed Web of Science ®Google Scholar
• Tsuji S, Kawano S, Tsujii M, Michida T, Masuda E, et al.: [Mucosal microcirculation and angiogenesis in gastrointestinal tract]. Nihon Rinsho 56, 2247–2252, 1998.
   PubMedGoogle Scholar
• Kakiuchi Y, Tsuji S, Tsujii M, Murata H, Kawai N, et al.: Cyclooxygenase-2 activity altered the cell-surface carbohydrate antigens on colon cancer cells and enhanced liver metastasis. Cancer Res 62, 1567–1572, 2002.
   PubMed Web of Science ®Google Scholar
• Krishnamachary B, Stasinopoulos I, Kakkad S, Penet MF, Jacob D, et al.: Breast cancer cell cyclooxygenase-2 expression alters extracellular matrix structure and function and numbers of cancer associated fibroblasts. Oncotarget 8, 17981–17994, 2017. doi:10.18632/oncotarget.14912.
   PubMedGoogle Scholar
• Maturu P, Jones D, Ruteshouser EC, Hu Q, Reynolds JM, et al.: Role of cyclooxygenase-2 pathway in creating an immunosuppressive microenvironment and in initiation and progression of Wilms' tumor. Neoplasia 19, 237–249, 2017. doi:10.1016/j.neo.2016.07.009.
   PubMed Web of Science ®Google Scholar
• Vandoros GP, Konstantinopoulos PA, Sotiropoulou-Bonikou G, Kominea A, Papachristou GI, et al.: PPAR-gamma is expressed and NF-KB pathway is activated and correlates positively with COX-2 expression in stromal myofibroblasts surrounding colon adenocarcinomas. J Cancer Res Clin Oncol 132, 76–84, 2006. doi:10.1007/s00432-005-0042-z.
   PubMed Web of Science ®Google Scholar
• Koki AT and Masferrer JL: Celecoxib: a specific COX-2 inhibitor with anticancer properties. Cancer Control 9, 28–35, 2002.
   PubMedGoogle Scholar
• Nagendraprabhu P and Sudhandiran G: Astaxanthin inhibits tumor invasion by decreasing extracellular matrix production and induces apoptosis in experimental rat colon carcinogenesis by modulating the expressions of ERK-2, NFkB and COX-2. Invest New Drugs 29, 207–224, 2011. doi:10.1007/s10637-009-9342-5.
   PubMed Web of Science ®Google Scholar
• Murakami A and Ohigashi H: Targeting NOX, INOS and COX-2 in inflammatory cells: chemoprevention using food phytochemicals. Int J Cancer 121, 2357–2363, 2007. doi:10.1002/ijc.23161.
   PubMed Web of Science ®Google Scholar
• Harris RE, Beebe-Donk J, and Alshafie GA: Reduction in the risk of human breast cancer by selective cyclooxygenase-2 (COX-2) inhibitors. BMC Cancer 6, 27, 2006. doi:10.1186/1471-2407-6-27.
   PubMed Web of Science ®Google Scholar
• Harris RE, Casto BC, and Harris ZM: Cyclooxygenase-2 and the inflammogenesis of breast cancer. World J Clin Oncol 5, 677–692, 2014. doi:10.5306/wjco.v5.i4.677.
   PubMedGoogle Scholar
• Rakoff-Nahoum S: Why cancer and inflammation? Yale J Biol Med 79, 123–130, 2006.
   PubMedGoogle Scholar
• Acheva A, Schettino G, and Prise KM: Pro-inflammatory signaling in a 3D organotypic skin model after low LET Irradiation-NF-kappaB, COX-2 activation, and impact on cell differentiation. Front Immunol 8, 82, 2017. doi:10.3389/fimmu.2017.00082.
   PubMed Web of Science ®Google Scholar
• Yao C, Li G, Cai M, Qian YY, Wang LQ, et al.: Prostate cancer downregulated SIRP-alpha modulates apoptosis and proliferation through p38-MAPK/NF-kappa B/COX-2 signaling. Oncol Lett 13, 4995–5001, 2017. doi:10.3892/ol.2017.6070.
   PubMed Web of Science ®Google Scholar
• Madka V and Rao CV: Anti-inflammatory phytochemicals for chemoprevention of colon cancer. Current Cancer Drug Targets 13, 542–557, 2013.
   PubMed Web of Science ®Google Scholar
• Yiannakopoulou EC: Interaction of salicylates and the other nonsteroidal anti-inflammatory agents with breast cancer endocrine treatment systematic review. Am J Clin Oncol-Cancer Clin Trials 38, 641–644, 2015. doi:10.1097/Coc.0000000000000166.
   PubMed Web of Science ®Google Scholar
• Conte E, Fagone E, Fruciano M, Gili E, Iemmolo M, et al.: Anti-inflammatory and antifibrotic effects of resveratrol in the lung. Histol Histopathol 30, 523–529, 2015. doi:10.14670/Hh-30.523.
   PubMed Web of Science ®Google Scholar
• Wang X, Lin YW, Wu J, Zhu Y, Xu XL, et al.: Meta-analysis of nonsteroidal anti-inflammatory drug intake and prostate cancer risk. World J Surg Oncol 12, 304, 2014. doi:10.1186/1477-7819-12-304.
   PubMed Web of Science ®Google Scholar
• Lourenco AM, Ferreira LM, and Branco PS: Molecules of natural origin, semi-synthesis and synthesis with anti-inflammatory and anticancer utilities. Curr Pharm Des 18, 3979–4046, 2012.
   PubMed Web of Science ®Google Scholar
• Orlikova B, Legrand N, Panning J, Dicato M, and Diederich M: Anti-inflammatory and anticancer drugs from nature. Adv Nutrition Cancer 159, 123–143, 2014. doi:10.1007/978-3-642-38007-5_8.
   Google Scholar
• De Stefano D, Maiuri MC, Simeon V, Grassia G, Soscia A, et al.: Lycopene, quercetin and tyrosol prevent macrophage activation induced by gliadin and IFN-gamma. Eur J Pharmacol 566, 192–199, 2007. doi:10.1016/j.ejphar.2007.03.051.
   PubMed Web of Science ®Google Scholar
• Venturini CM, Isakson P, and Needleman P: Non-steroidal anti-inflammatory drug-induced renal failure: a brief review of the role of cyclo-oxygenase isoforms. Curr Opin Nephrol Hypertens 7, 79–82, 1998.
   PubMed Web of Science ®Google Scholar
• Hoffmann A, Levchenko A, Scott ML, and Baltimore D: The IkappaB-NF-kappaB signaling module: temporal control and selective gene activation. Science 298, 1241–1245, 2002. doi:10.1126/science.1071914.
   PubMed Web of Science ®Google Scholar
• Liu F, Xia Y, Parker AS, and Verma IM: IKK biology. Immunol Rev 246, 239–253, 2012. doi:10.1111/j.1600-065X.2012.01107.x.
   PubMed Web of Science ®Google Scholar
• Basak S and Hoffmann A: Crosstalk via the NF-kappa B signaling system. Cytokine Growth Factor Rev 19, 187–197, 2008. doi:10.1016/j.cytogfr.2008.04.005.
   PubMed Web of Science ®Google Scholar
• Karin M and Ben-Neriah Y: Phosphorylation meets ubiquitination: The control of NF-kappa B activity. Annu Rev Immunol 18, 621–663, 2000. doi:10.1146/annurev.immunol.18.1.621.
   PubMed Web of Science ®Google Scholar
• Ben-Neriah Y: Regulatory functions of ubiquitination in the immune system. Nat Immunol 3, 20–26, 2002. doi:10.1038/ni0102-20.
   PubMed Web of Science ®Google Scholar
• Lappas M, Permezel M, Georgiou HM, and Rice GE: Nuclear factor kappa B regulation of proinflammatory cytokines in human gestational tissues in vitro. Biol Reprod 67, 668–673, 2002. doi:10.1095/biolreprod67.2.668.
   PubMed Web of Science ®Google Scholar
• Alves BN, Tsui R, Almaden J, Shokhirev MN, Davis-Turak J, et al.: I kappa B epsilon is a key regulator of B cell expansion by providing negative feedback on cRel and RelA in a stimulus-specific manner. J Immunol 192, 3121–3132, 2014. doi:10.4049/jimmunol.1302351.
   PubMed Web of Science ®Google Scholar
• Escoubet-Lozach L, Benner C, Kaikkonen MU, Lozach J, Heinz S, et al.: Mechanisms establishing TLR4-responsive activation states of inflammatory response genes. Plos Genetics 7, e1002401, 2011. doi:10.1371/journal.pgen.1002401.
   PubMed Web of Science ®Google Scholar
• Wong MM and Fish EN: Chemokines: attractive mediators of the immune response. Semin Immunol 15, 5–14, 2003. doi:10.1016/S1044-5323(02)00123-9.
   PubMed Web of Science ®Google Scholar
• Rossi A, Kapahi P, Natoli G, Takahashi T, Chen Y, et al.: Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of I kappa B kinase. Nature 403, 103–108, 2000.
   PubMed Web of Science ®Google Scholar
• Yamamoto Y and Gaynor RB: Therapeutic potential of inhibition of the NF-kappa B pathway in the treatment of inflammation and cancer. J Clin Invest 107, 135–142, 2001. doi:10.1172/Jci11914.
   PubMed Web of Science ®Google Scholar
• Johnson GL and Lapadat R: Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science 298, 1911–1912, 2002. doi:10.1126/science.1072682.
   PubMed Web of Science ®Google Scholar
• Carter AB, Knudtson KL, Monick MM, and Hunninghake GW: The p38 mitogen-activated protein kinase is required for NF-kappa B-dependent gene expression – The role of TATA-binding protein (TBP). J Biol Chem 274, 30858–30863, 1999. doi:10.1074/jbc.274.43.30858.
   PubMed Web of Science ®Google Scholar
• Huang F, Cao J, Liu Q, Zou Y, Li H, et al.: MAPK/ERK signal pathway involved expression of COX-2 and VEGF by IL-1beta induced in human endometriosis stromal cells in vitro. Int J Clin Exp Pathol 6, 2129–2136, 2013.
   PubMed Web of Science ®Google Scholar
• Di Mari JF, Saada JI, Mifflin RC, Valentich JD, and Powell DW: HETEs enhance IL-1-mediated COX-2 expression via augmentation of message stability in human colonic myofibroblasts. Am J Physiol-Gastrointest Liver Physiol 293, G719–G728, 2007. doi:10.1152/ajpgi.00117.2007.
   PubMed Web of Science ®Google Scholar
• Pei XY, Dai Y, Tenorio S, Lu J, Harada H, et al.: MEK1/2 inhibitors potentiate UCN-01 lethality in human multiple myeloma cells through a Bim-dependent mechanism. Blood 110, 2092–2101, 2007. doi:10.1182/blood-2007-04-083204.
   PubMed Web of Science ®Google Scholar
• Cuenda A and Rousseau S: P38 MAP-Kinases pathway regulation, function and role in human diseases. Biochim Biophys Acta-Mol Cell Res 1773, 1358–1375, 2007. doi:10.1016/j.bbamcr2007.03.010.
   PubMed Web of Science ®Google Scholar
• Zarubin T and Han JH: Activation and signaling of the p38 MAP kinase pathway. Cell Res 15, 11–18, 2005. doi:10.1038/sj.cr.7290257.
   PubMed Web of Science ®Google Scholar
• Lopez-Bergami P, Lau E, and Ronai Z: Emerging roles of ATF2 and the dynamic AP1 network in cancer. Nat Rev Cancer 10, 379, 2010. doi:10.1038/nrc2846.
   Web of Science ®Google Scholar
• Lopez-Bergami P, Lau E, and Ronai Z: OPINION Emerging roles of ATF2 and the dynamic AP1 network in cancer. Nat Rev Cancer 10, 65–76, 2010. doi:10.1038/nrc2681.
   PubMed Web of Science ®Google Scholar
• Simmons DL, Botting RM, and Hla T: Cyclooxygenase isozymes: the biology of prostaglandin synthesis and inhibition. Pharmacol Rev 56, 387–437, 2004. doi:10.1124/pr.56.3.3.
   PubMed Web of Science ®Google Scholar
• Maroon JC, Bost JW, Borden MK, Lorenz KM, and Ross NA: Natural antiinflammatory agents for pain relief in athletes. Neurosurg Focus 21, E11, 2006.
   PubMedGoogle Scholar
• Burton TM: Monsanto arthritis-pain drug, Celebrex, surpasses Viagra's early sales success. The Wall Street Journal: New York, 1999.
   Google Scholar
• Ehrich EW, Dallob A, De Lepeleire I, Van Hecken A, Riendeau D, et al.: Characterization of rofecoxib as a cyclooxygenase-2 isoform inhibitor and demonstration of analgesia in the dental pain model. Clin Pharmacol Ther 65, 336–347, 1999. doi:10.1016/S0009-9236(99)70113-X.
   PubMed Web of Science ®Google Scholar
• Boyles S: Vioxx, Celebrex Were Overused, Study Shows 3/4 of Users Had Little Need for Cox-2 Inhibitors, WebMD, 2005.
   Google Scholar
• Ahmaditaba MA, Shahosseini S, Daraei B, Zarghi A, and Houshdar Tehrani MH: Design, synthesis, and biological evaluation of new peptide analogues as selective COX-2 inhibitors. Arch Pharm (Weinheim) 350, 2017. doi:10.1002/ardp.201700158.
   PubMed Web of Science ®Google Scholar
• FitzGerald GA: Coxibs and cardiovascular disease. New Engl J Med 351, 1709–1711, 2004. doi:10.1056/NEJMp048288.
   PubMed Web of Science ®Google Scholar
• Bresalier RS, Sandler RS, Quan H, Bolognese JA, Oxenius B, et al.: Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial. New Engl J Med 352, 1092–1102, 2005. doi:10.1056/NEJMoa050493.
   PubMed Web of Science ®Google Scholar
• Nussmeier NA, Whelton AA, Brown MT, Langford RM, Hoeft A, et al.: Complications of the COX-2 inhibitors parecoxib and valdecoxib after cardiac surgery. New Engl J Med 352, 1081–1091, 2005. doi:10.1056/NEJMoa050330.
   PubMed Web of Science ®Google Scholar
• Solomon SD, McMurray JJV, Pfeffer MA, Wittes J, Fowler R, et al.: Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention. New Engl J Med 352, 1071–1080, 2005. doi:10.1056/NEJMoa050405.
   PubMed Web of Science ®Google Scholar
• Kaur C and Kapoor HC: Antioxidants in fruits and vegetables – the millennium's health. Int J Food Sci Technol 36, 703–725, 2001. doi:10.1046/j.1365-2621.2001.00513.x.
   Web of Science ®Google Scholar
• Liu RH: Potential synergy of phytochemicals in cancer prevention: mechanism of action. J Nutrition 134, 3479s–3485s, 2004.
   PubMed Web of Science ®Google Scholar
• Reddy MK, Alexander-Lindo RL, and Nair MG: Relative inhibition of lipid peroxidation, cyclooxygenase enzymes, and human tumor cell proliferation by natural food colors. J Agric Food Chem 53, 9268–9273, 2005. doi:10.1021/jf051399j.
   PubMed Web of Science ®Google Scholar
• Palozza P, Serini S, Maggiano N, Tringali G, Navarra P, et al.: beta-Carotene downregulates the steady-state and heregulin-alpha-induced COX-2 pathways in colon cancer cells. J Nutr 135, 129–136, 2005. doi:10.1093/jn/135.1.129.
   PubMed Web of Science ®Google Scholar
• Palozza P, Serini S, Maggiano N, Tringali G, Navarra P, et al.: beta-carotene downregulates the steady-state and heregulin-alpha-induced COX-2 pathways in colon cancer cells. J Nutr 135, 129–136, 2005.
   PubMed Web of Science ®Google Scholar
• Singh S, Pandey VP, Naaz H, Singh P, and Dwivedi UN: Structural modeling and simulation studies of human cyclooxygenase (COX) isozymes with selected terpenes: implications in drug designing and development. Comput Biol Med 43, 744–750, 2013. doi:10.1016/j.compbiomed.2013.02.019.
   PubMed Web of Science ®Google Scholar
• Wang SC, Lien HC, Xia WY, Chen IF, Lo HW, et al.: Binding at and transactivation of the COX-2 promoter by nuclear tyrosine kinase receptor ErbB-2. Cancer Cell 6, 251–261, 2004. doi:10.1016/j.ccr.2004.07.012.
   PubMed Web of Science ®Google Scholar
• Breuleux M: Role of heregulin in human cancer. Cell Mol Life Sci 64, 2358–2377, 2007. doi:10.1007/s00018-007-7120-0.
   PubMed Web of Science ®Google Scholar
• Firdous AP, Kuttan G, and Kuttan R: Anti-inflammatory potential of carotenoid meso-zeaxanthin and its mode of action. Pharm Biol 53, 961–967, 2015. doi:10.3109/13880209.2014.950673.
   PubMed Web of Science ®Google Scholar
• Talero E, Avila-Roman J, and Motilva V: Chemoprevention with phytonutrients and microalgae products in chronic inflammation and colon cancer. Curr Pharm Des 18, 3939–3965, 2012. doi:10.2174/138161212802083725.
   PubMed Web of Science ®Google Scholar
• Park JH, Yeo IJ, Han JH, Suh JW, Lee HP, et al.: Anti-inflammatory effect of astaxanthin in phthalic anhydride-induced atopic dermatitis animal model. Exp Dermatol 2017. doi:10.1111/exd.13437.
   Web of Science ®Google Scholar
• Yasui Y, Hosokawa M, Mikami N, Miyashita K, and Tanaka T: Dietary astaxanthin inhibits colitis and colitis-associated colon carcinogenesis in mice via modulation of the inflammatory cytokines. Chem-Biol Interact 193, 79–87, 2011. doi:10.1016/j.cbi.2011.05.006.
   PubMed Web of Science ®Google Scholar
• Nagendraprabhu P and Sudhandiran G: Astaxanthin inhibits tumor invasion by decreasing extracellular matrix production and induces apoptosis in experimental rat colon carcinogenesis by modulating the expressions of ERK-2, NFkB and COX-2. Invest New Drugs 29, 207–224, 2011. doi:10.1007/s10637-009-9342-5.
   PubMed Web of Science ®Google Scholar
• Krishnaswamy R, Devaraj SN, and Padma VV: Lutein protects HT-29 cells against Deoxynivalenol-induced oxidative stress and apoptosis: prevention of NF-kappaB nuclear localization and down regulation of NF-kappaB and Cyclo-Oxygenase-2 expression. Free Radic Biol Med 49, 50–60, 2010. doi:10.1016/j.freeradbiomed.2010.03.016.
   PubMed Web of Science ®Google Scholar
• Oh J, Kim JH, Park JG, Yi YS, Park KW, et al.: Radical scavenging activity-based and AP-1-targeted anti-inflammatory effects of lutein in macrophage-like and skin keratinocytic cells. Mediat Inflamm 2013, 2013. doi:10.1155/2013/787042.
   Web of Science ®Google Scholar
• Palozza P, Parrone N, Catalano A, and Simone R: Tomato lycopene and inflammatory cascade: basic interactions and clinical implications. Curr Med Chem 17, 2547–2563, 2010. doi:10.2174/092986710791556041.
   PubMed Web of Science ®Google Scholar
• Palozza P, Sheriff A, Serini S, Boninsegna A, Maggiano N, et al.: Lycopene induces apoptosis in immortalized fibroblasts exposed to tobacco smoke condensate through arresting cell cycle and down-regulating cyclin D1, pAKT and pBad. Apoptosis 10, 1445–1456, 2005. doi:10.1007/s10495-005-1393-2.
   PubMed Web of Science ®Google Scholar
• Vasconcelos AG, Amorim A, Dos Santos RC, Souza JMT, de Souza LKM, et al.: Lycopene rich extract from red guava (Psidium guajava L.) displays anti-inflammatory and antioxidant profile by reducing suggestive hallmarks of acute inflammatory response in mice. Food Res Int 99, 959–968, 2017. doi:10.1016/j.foodres.2017.01.017.
   PubMed Web of Science ®Google Scholar
• Lin HY, Huang BR, Yeh WL, Lee CH, Huang SS, et al.: Antineuroinflammatory effects of lycopene via activation of adenosine monophosphate-activated protein kinase-alpha 1/heme oxygenase-1 pathways. Neurobiol. Aging 35, 191–202, 2014. doi:10.1016/j.neurobiolaging.2013.06.020.
   PubMed Web of Science ®Google Scholar
• Tang FY, Pai MH, and Wang XD: Consumption of lycopene inhibits the growth and progression of colon cancer in a mouse xenograft model. J Agric Food Chem 59, 9011–9021, 2011. doi:10.1021/jf2017644.
   PubMed Web of Science ®Google Scholar
• Tang FY, Pai MH, Kuo YH, and Wang XD: Concomitant consumption of lycopene and fish oil inhibits tumor growth and progression in a mouse xenograft model of colon cancer. Mol Nutr Food Res 56, 1520–1531, 2012. doi:10.1002/mnfr.201200098.
   PubMed Web of Science ®Google Scholar
• Chan JM, Weinberg V, Magbanua MJ, Sosa E, Simko J, et al.: Nutritional supplements, COX-2 and IGF-1 expression in men on active surveillance for prostate cancer. Cancer Causes Control 22, 141–150, 2011. doi:10.1007/s10552-010-9684-5.
   PubMed Web of Science ®Google Scholar
• Huang WY, Cai YZ, and Zhang Y: Natural phenolic compounds from medicinal herbs and dietary plants: potential use for cancer prevention. Nutr Cancer 62, 1–20, 2010. doi:10.1080/01635580903191585.
   PubMed Web of Science ®Google Scholar
• Subbaramaiah K, Sue E, Bhardwaj P, Du B, Hudis CA, et al.: Dietary polyphenols suppress elevated levels of proinflammatory mediators and aromatase in the mammary gland of obese mice. Cancer Prev Res (Phila) 6, 886–897, 2013. doi:10.1158/1940-6207.CAPR-13-0140.
   PubMed Web of Science ®Google Scholar
• Scoditti E, Calabriso N, Massaro M, Pellegrino M, Storelli C, et al.: Mediterranean diet polyphenols reduce inflammatory angiogenesis through MMP-9 and COX-2 inhibition in human vascular endothelial cells: A potentially protective mechanism in atherosclerotic vascular disease and cancer. Arch Biochem Biophys 527, 81–89, 2012. doi:10.1016/j.abb.2012.05.003.
   PubMed Web of Science ®Google Scholar
• Woo JH, Lim JH, Kim YH, Suh SI, Min DS, et al.: Resveratrol inhibits phorbol myristate acetate-induced matrix metalloproteinase-9 expression by inhibiting JNK and PKC delta signal transduction. Oncogene 23, 1845–1853, 2004. doi:10.1038/sj.onc.1207307.
   PubMed Web of Science ®Google Scholar
• Malhotra A, Nair P, and Dhawan DK: Curcumin and resveratrol synergistically stimulate p21 and regulate cox-2 by maintaining adequate zinc levels during lung carcinogenesis. Eur J Cancer Prev 20, 411–416, 2011. doi:10.1097/CEJ.0b013e3283481d71.
   PubMed Web of Science ®Google Scholar
• Sharma RA, Gescher AJ, and Steward WP: Curcumin: the story so far. Eur J Cancer 41, 1955–1968, 2005. doi:10.1016/j.ejca.2005.05.009.
   PubMed Web of Science ®Google Scholar
• Lee YK, Park SY, Kim YM, and Park OJ: Regulatory effect of the AMPK-COX-2 signaling pathway in curcumin-induced apoptosis in HT-29 colon cancer cells. Nat. Compd. Their Role Apoptotic Cell Signaling Pathways 1171, 489–494, 2009. doi:10.1111/j.1749-6632.2009.04699.x.
   Web of Science ®Google Scholar
• Jiang H, Deng CS, Zhang M, and Xia J: Curcumin-attenuated trinitrobenzene sulphonic acid induces chronic colitis by inhibiting expression of cyclooxygenase-2. World J Gastroenterol 12, 3848–3853, 2006
   PubMed Web of Science ®Google Scholar
• Gibson PR: Increased gut permeability in Crohn's disease: is TNF the link? Gut 53, 1724–1725, 2004. doi:10.1136/gut.2004.047092
   PubMed Web of Science ®Google Scholar
• Chun KS, Keum YS, Han SS, Song YS, Kim SH, et al.: Curcumin inhibits phorbol ester-induced expression of cyclooxygenase-2 in mouse skin through suppression of extracellular signal-regulated kinase activity and NF-kappa B activation. Carcinogenesis 24, 1515–1524, 2003. doi:10.1093/carcin/bgg107.
   PubMed Web of Science ®Google Scholar
• Griesser M, Pistis V, Suzuki T, Tejera N, Pratt DA, et al.: Autoxidative and cyclooxygenase-2 catalyzed transformation of the dietary chemopreventive agent curcumin. J Biol Chem 286, 1114–1124, 2011. doi:10.1074/jbc.M110.178806.
   PubMed Web of Science ®Google Scholar
• Yarla NS, Bishayee A, Sethi G, Reddanna P, Kalle AM, et al.: Targeting arachidonic acid pathway by natural products for cancer prevention and therapy. Semin Cancer Biol 40–41, 48-81, 2016. doi:10.1016/j.semcancer.2016.02.001.
   PubMed Web of Science ®Google Scholar
• Hong J, Bose M, Ju J, Ryu JH, Chen X, et al.: Modulation of arachidonic acid metabolism by curcumin and related beta-diketone derivatives: effects on cytosolic phospholipase A(2), cyclooxygenases and 5-lipoxygenase. Carcinogenesis 25, 1671–1679, 2004. doi:10.1093/carcin/bgh165
   PubMed Web of Science ®Google Scholar
• Marin YE, Wall BA, Wang S, Namkoong J, Martino JJ, et al.: Curcumin downregulates the constitutive activity of NF-kappaB and induces apoptosis in novel mouse melanoma cells. Melanoma Res 17, 274–283, 2007. doi:10.1097/CMR.0b013e3282ed3d0e.
   PubMed Web of Science ®Google Scholar
• Rajitha B, Nagaraju GP, Shaib WL, Alese OB, Snyder JP, et al.: Novel synthetic curcumin analogs as potent antiangiogenic agents in colorectal cancer. Mol Carcinog 56, 288–299, 2017.
   Web of Science ®Google Scholar
• Shishodia S, Potdar P, Gairola CG, and Aggarwal BB: Curcumin (diferuloylmethane) down-regulates cigarette smoke-induced NF-kappa B activation through inhibition of I kappa B alpha kinase in human lung epithelial cells: correlation with suppression of COX-2, MMP-9 and cyclin D1. Carcinogenesis 24, 1269–1279, 2003. doi:10.1093/carcin/bgg078.
   PubMed Web of Science ®Google Scholar
• Shrestha S, Zhu J, Wang Q, Du X, Liu F, et al.: Melatonin potentiates the antitumor effect of curcumin by inhibiting IKKbeta/NF-kappaB/COX-2 signaling pathway. Int J Oncol 51, 1249–1260, 2017. doi:10.3892/ijo.2017.4097.
   PubMed Web of Science ®Google Scholar
• Bahadori F and Demiray M: A realistic view on “The essential medicinal chemistry of curcumin”. ACS Med Chem Lett 8, 893–896, 2017. doi:10.1021/acsmedchemlett.7b00284.
   PubMed Web of Science ®Google Scholar
• Plummer SM, Holloway KA, Manson MM, Munks RJ, Kaptein A, et al.: Inhibition of cyclo-oxygenase 2 expression in colon cells by the chemopreventive agent curcumin involves inhibition of NF-kappaB activation via the NIK/IKK signalling complex. Oncogene 18, 6013–6020, 1999. doi:10.1038/sj.onc.1202980.
   PubMed Web of Science ®Google Scholar
• Lee CW, Lin CC, Lee IT, Lee HC, and Yang CM: Activation and induction of cytosolic phospholipase A2 by TNF-alpha mediated through Nox2, MAPKs, NF-kappaB, and p300 in human tracheal smooth muscle cells. J Cell Physiol 226, 2103–2114, 2011. doi:10.1002/jcp.22537.
   PubMed Web of Science ®Google Scholar
• Lee KW, Kim JH, Lee HJ, and Surh YJ: Curcumin inhibits phorbol ester-induced up-regulation of cyclooxygenase-2 and matrix metalloproteinase-9 by blocking ERK1/2 phosphorylation and NF-kappaB transcriptional activity in MCF10A human breast epithelial cells. Antioxid Redox Signal 7, 1612–1620, 2005. doi:10.1089/ars.2005.7.1612.
   PubMed Web of Science ®Google Scholar
• Guimaraes MR, Leite FR, Spolidorio LC, Kirkwood KL, Rossa C, Jr.: Curcumin abrogates LPS-induced pro-inflammatory cytokines in RAW 264.7 macrophages. Evidence for novel mechanisms involving SOCS-1, -3 and p38 MAPK. Arch Oral Biol 58, 1309–1317, 2013. doi:10.1016/j.archoralbio.2013.07.005.
   PubMed Web of Science ®Google Scholar
• Kang G, Kong PJ, Yuh YJ, Lim SY, Yim SV, et al.: Curcumin suppresses lipopolysaccharide-induced cyclooxygenase-2 expression by inhibiting activator protein 1 and nuclear factor kappab bindings in BV2 microglial cells. J Pharmacol Sci 94, 325–328, 2004
   PubMed Web of Science ®Google Scholar
• Shah VO, Ferguson JE, Hunsaker LA, Deck LM, and Vander Jagt DL: Natural products inhibit LPS-induced activation of pro-inflammatory cytokines in peripheral blood mononuclear cells. Nat Prod Res 24, 1177–1188, 2010. doi:10.1080/14786410903112680.
   PubMed Web of Science ®Google Scholar
• Cheng SE, Luo SF, Jou MJ, Lin CC, Kou YR, et al.: Cigarette smoke extract induces cytosolic phospholipase A2 expression via NADPH oxidase, MAPKs, AP-1, and NF-kappaB in human tracheal smooth muscle cells. Free Radic Biol Med 46, 948–960, 2009
   PubMed Web of Science ®Google Scholar
• Ferruelo A, de Las Heras MM, Redondo C, Ramon de Fata F, Romero I, et al.: Wine polyphenols exert antineoplasic effect on androgen resistant PC-3 cell line through the inhibition of the transcriptional activity of COX-2 promoter mediated by NF-kbeta. Actas Urol Esp 38, 429–437, 2014. doi:10.1016/j.acuro.2014.02.017.
   PubMed Web of Science ®Google Scholar
• Wang GX, Dai F, Yu K, Jia ZF, Zhang AL, et al.: Resveratrol inhibits glioma cell growth via targeting oncogenic microRNAs and multiple signaling pathways. Int J Oncol 46, 1739–1747, 2015. doi:10.3892/ijo.2015.2863.
   PubMed Web of Science ®Google Scholar
• Li C, Tang C, and He G: Tristetraprolin: a novel mediator of the anticancer properties of resveratrol. Genet Mol Res 15, 2016. doi:10.4238/gmr.15027213.
   Web of Science ®Google Scholar
• Harikumar KB, Kunnumakkara AB, Sethi G, Diagaradjane P, Anand P, et al.: Resveratrol, a multitargeted agent, can enhance antitumor activity of gemcitabine in vitro and in orthotopic mouse model of human pancreatic cancer. Int J Cancer 127, 257–268, 2010. doi:10.1002/ijc.25041.
   PubMed Web of Science ®Google Scholar
• Serra D, Rufino AT, Mendes AF, Almeida LM, and Dinis TCP: Resveratrol modulates cytokine-induced JAK/STAT activation more efficiently than 5-aminosalicylic acid: An in vitro approach. Plos One 9, e109048, 2014. doi:10.1371/journal.pone.0109048
   PubMed Web of Science ®Google Scholar
• Zykova TA, Zhu F, Zhai XH, Ma WY, Ermakova SP, et al.: Resveratrol directly targets COX-2 to inhibit carcinogenesis. Mol Carcinog 47, 797–805, 2008. doi:10.1002/mc.20437.
   PubMed Web of Science ®Google Scholar
• Rai G, Mishra S, Suman S, Shukla Y: Resveratrol improves the anticancer effects of doxorubicin in vitro and in vivo models: a mechanistic insight. Phytomedicine 23, 233–242, 2016. doi:10.1016/j.phymed.2015.12.020.
   PubMed Web of Science ®Google Scholar
• Kang OH, Jang HJ, Chae HS, Oh YC, Choi JG, et al.: Anti-inflammatory mechanisms of resveratrol in activated HMC-1 cells: pivotal roles of NF-kappa B and MAPK. Pharmacol Res 59, 330–337, 2009. doi:10.1016/j.phrs.2009.01.009.
   PubMed Web of Science ®Google Scholar
• Banerjee S, Bueso-Ramos C, and Aggarwal BB: Suppression of 7,12-dimethylbenz(a)anthracene-induced mammary carcinogenesis in rats by resveratrol: role of nuclear factor-kappa B, cyclooxygenase 2, and matrix metalloprotease 9. Cancer Res 62, 4945–4954, 2002.
   PubMed Web of Science ®Google Scholar
• Lin HY, Delmas D, Vang O, Hsieh TC, Lin S, et al.: Mechanisms of ceramide-induced COX-2-dependent apoptosis in human ovarian cancer OVCAR-3 cells partially overlapped with resveratrol. J Cell Biochem 114, 1940–1954, 2013. doi:10.1002/jcb.24539.
   PubMed Web of Science ®Google Scholar
• Huang CS, Ma WY, Goranson A, and Dong ZG: Resveratrol suppresses cell transformation and induces apoptosis through a p53-dependent pathway. Carcinogenesis 20, 237–242, 1999. doi:10.1093/carcin/20.2.237.
   PubMed Web of Science ®Google Scholar
• Lin C, Crawford DR, Lin S, Hwang J, Sebuyira A, et al.: Inducible COX-2-dependent apoptosis in human ovarian cancer cells. Carcinogenesis 32, 19–26, 2011. doi:10.1093/carcin/bgq212.
   PubMed Web of Science ®Google Scholar
• Park SA, Na HK, and Surh YJ: Resveratrol suppresses 4-hydroxyestradiol-induced transformation of human breast epithelial cells by blocking I kappa B kinase beta-NF-kappa B signalling. Free Radical Research 46, 1051–1057, 2012. doi:10.3109/10715762.2012.671940.
   PubMed Web of Science ®Google Scholar
• Lin HY, Tang HY, Davis FB, and Davis PJ: Resveratrol and apoptosis. Resveratrol Health 1215, 79–88, 2011. doi:10.1111/j.1749-6632.2010.05846.x.
   Web of Science ®Google Scholar
• Murakami A, Nakamura Y, Koshimizu K, Takahashi D, Matsumoto K, et al.: FA15, a hydrophobic derivative of ferulic acid, suppresses inflammatory responses and skin tumor promotion: comparison with ferulic acid. Cancer Lett 180, 121–129, 2002. doi:10.1016/S0304-3835(01)00858-8.
   PubMed Web of Science ®Google Scholar
• Hirata A, Murakami Y, Atsumi T, Shoji M, Ogiwara T, et al.: Ferulic acid dimer inhibits lipopolysaccharide-stimulated cyclooxygenase-2 expression in macrophages. In Vivo 19, 849–853, 2005.
   PubMed Web of Science ®Google Scholar
• Chung CP, Hsu HY, Huang DW, Hsu HH, Lin JT, et al.: Ethyl acetate fraction of adlay bran ethanolic extract inhibits oncogene expression and suppresses DMH-induced preneoplastic lesions of the colon in f344 rats through an anti-inflammatory pathway. J Agric Food Chem 58, 7616–7623, 2010. doi:10.1021/jf101084e.
   PubMed Web of Science ®Google Scholar
• Jayaprakasam B, Vanisree M, Zhang YJ, Dewitt DL, and Nair MG: Impact of alkyl esters of caffeic and ferulic acids on tumor cell proliferation, cyclooxygenase enzyme, and lipid peroxidation. J Agric Food Chem 54, 5375–5381, 2006. doi:10.1021/jf060899p.
   PubMed Web of Science ®Google Scholar
• Das U, Manna K, Sinha M, Datta S, Das DK, et al.: Role of ferulic acid in the amelioration of ionizing radiation induced inflammation: a murine model. Plos One 9, e97599, 2014. doi:10.1371/journal.pone.0097599.
   PubMed Web of Science ®Google Scholar
• Shindo Y, Witt E, Han D, Epstein W, and Packer L: Enzymic and non-enzymic antioxidants in epidermis and dermis of human skin. J Invest Dermatol 102, 122–124, 1994.
   PubMed Web of Science ®Google Scholar
• Nishikimi M, Fukuyama R, Minoshima S, Shimizu N, and Yagi K: Cloning and chromosomal mapping of the human nonfunctional gene for L-gulono-gamma-lactone oxidase, the enzyme for L-ascorbic-acid biosynthesis missing in man. J Biol Chem 269, 13685–13688, 1994.
   PubMed Web of Science ®Google Scholar
• Thiele JJ: Oxidative targets in the stratum corneum. Skin Pharmacol Appl Skin Physiol 14, 87–91, 2001. doi:10.1159/000056395.
   PubMedGoogle Scholar
• Pinnell SR, Yang H, Omar M, Monteiro-Riviere N, DeBuys HV, et al.: Topical L-ascorbic acid: percutaneous absorption studies. Dermatol Surg 27, 137–142, 2001.
   PubMed Web of Science ®Google Scholar
• Zielinski JE and Pinnell S: Stabilized Ascorbic Acid Compositions and Methods Thereof , U.S. patent 7,179,841 B2, 2004.
   Google Scholar
• Lin JY, Selim MA, Shea CR, Grichnik JM, Omar MM, et al.: UV photoprotection by combination topical antioxidants vitamin C and vitamin E. J Am Acad Dermatol 48, 866–874, 2003. doi:10.1067/mjd.2003.425.
   PubMed Web of Science ®Google Scholar
• Fajardo AM and Piazza GA: Chemoprevention in gastrointestinal physiology and disease. Anti-inflammatory approaches for colorectal cancer chemoprevention. Am J Physiol Gastrointest Liver Physiol 309, G59–G70, 2015. doi:10.1152/ajpgi.00101.2014.
   PubMed Web of Science ®Google Scholar
• Romagnolo DF and Selmin OI: Flavonoids and cancer prevention: a review of the evidence. J Nutr Gerontol Geriatr 31, 206–238, 2012. doi:10.1080/21551197.2012.702534.
   PubMedGoogle Scholar
• Chung MY, Mah E, Masterjohn C, Noh SK, Park HJ, et al.: Green tea lowers hepatic COX-2 and prostaglandin E2 in rats with dietary fat-induced nonalcoholic steatohepatitis. J Med Food 18, 648–655, 2015. doi:10.1089/jmf.2014.0048.
   PubMed Web of Science ®Google Scholar
• Shirakami Y, Shimizu M, Tsurumi H, Hara Y, Tanaka T, et al.: EGCG and polyphenon E attenuate inflammation-related mouse colon carcinogenesis induced by AOM plus DDS. Mol Med Rep 1, 355–361, 2008.
   PubMed Web of Science ®Google Scholar
• Park IJ, Lee YK, Hwang JT, Kwon DY, Ha J, et al.: Green tea catechin controls apoptosis in colon cancer cells by attenuation of H2O2-stimulated COX-2 expression via the AMPK signaling pathway at low-dose H2O2. Ann N Y Acad Sci 1171, 538–544, 2009. doi:10.1111/j.1749-6632.2009.04698.x.
   PubMed Web of Science ®Google Scholar
• Singh T and Katiyar SK: Green tea catechins reduce invasive potential of human melanoma cells by targeting COX-2, PGE(2) receptors and epithelial-to-mesenchymal transition. Plos One 6, e25224, 2011. doi:10.1371/journal.pone.0025224
   PubMed Web of Science ®Google Scholar
• Shi J, Liu F, Zhang W, Liu X, Lin B, et al.: Epigallocatechin-3-gallate inhibits nicotine-induced migration and invasion by the suppression of angiogenesis and epithelial-mesenchymal transition in non-small cell lung cancer cells. Oncol Rep 33, 2972–2980, 2015. doi:10.3892/or.2015.3889.
   PubMed Web of Science ®Google Scholar
• Kilic U, Sahin K, Tuzcu M, Basak N, Orhan C, et al.: Enhancement of cisplatin sensitivity in human cervical cancer: epigallocatechin-3-gallate. Front Nutr 1 (28), 2014. doi:10.3389/fnut.2014.00028.
   PubMedGoogle Scholar
• Ye F, Zhang GH, Guan BX, and Xu XC: Suppression of esophageal cancer cell growth using curcumin, (-)-epigallocatechin-3-gallate and lovastatin. World J Gastroenterol 18, 126–135, 2012. doi:10.3748/wjg.v18.i2.126.
   PubMed Web of Science ®Google Scholar
• Hwang JT, Ha J, Park IJ, Lee SK, Baik HW, et al.: Apoptotic effect of EGCG in HT-29 colon cancer cells via AMPK signal pathway. Cancer Lett 247, 115–121, 2007. doi:10.1016/j.canlet.2006.03.030.
   PubMed Web of Science ®Google Scholar
• Singh T and Katiyar SK: Green tea polyphenol, (-)-epigallocatechin-3-gallate, induces toxicity in human skin cancer cells by targeting beta-catenin signaling. Toxicol Appl Pharmacol 273, 418–424, 2013. doi:10.1016/j.taap.2013.09.021.
   PubMed Web of Science ®Google Scholar
• Peng G, Dixon DA, Muga SJ, Smith TJ, and Wargovich MJ: Green tea polyphenol (-)-epigallocatechin-3-gallate inhibits cyclooxygenase-2 expression in colon carcinogenesis. Mol Carcinog 45, 309–319, 2006. doi:10.1002/mc.20166.
   PubMed Web of Science ®Google Scholar
• Kim SY, Ahn BH, Min KJ, Lee YH, Joe EH, et al.: Phospholipase D isozymes mediate epigallocatechin gallate-induced cyclooxygenase-2 expression in astrocyte cells. J Biol Chem 279, 38125–38133, 2004. doi:10.1074/jbc.M402085200.
   PubMed Web of Science ®Google Scholar
• Raja SB, Rajendiran V, Kasinathan NK, Amrithalakshmi P, Venkatabalasubramanian S, et al.: Differential cytotoxic activity of Quercetin on colonic cancer cells depends on ROS generation through COX-2 expression. Food Chem Toxicol 106, 92–106, 2017. doi:10.1016/j.fct.2017.05.006.
   PubMed Web of Science ®Google Scholar
• Al-Fayez M, Cai H, Tunstall R, Steward WP, and Gescher AJ: Differential modulation of cyclooxygenase-mediated prostaglandin production by the putative cancer chemopreventive flavonoids tricin, apigenin and quercetin. Cancer Chemother Pharmacol 58, 816–825, 2006. doi:10.1007/s00280-006-0228-3.
   PubMed Web of Science ®Google Scholar
• Granado-Serrano AB, Martin MA, Bravo L, Goya L, and Ramos S: Quercetin attenuates TNF-induced inflammation in hepatic cells by inhibiting the NF-kappa B pathway. Nutr Cancer-Int J 64, 588–598, 2012. doi:10.1080/01635581.2012.661513.
   PubMed Web of Science ®Google Scholar
• Han MY, Song YC, and Zhang XD: Quercetin suppresses the migration and invasion in human colon cancer caco-2 cells through regulating toll-like receptor 4/nuclear factor-kappa B pathway. Pharmacognosy Mag 12, S237–S244, 2016. doi:10.4103/0973-1296.182154.
   PubMed Web of Science ®Google Scholar
• Ma JQ, Li Z, Xie WR, Liu CM, and Liu SS: Quercetin protects mouse liver against CCl4-induced inflammation by the TLR2/4 and MAPK/NF-kappa B pathway. Int Immunopharmacol 28, 531–539, 2015. doi:10.1016/j.intimp.2015.06.036.
   PubMed Web of Science ®Google Scholar
• Kim SH, Park JG, Hong YD, Kim E, Baik KS, et al.: Src/Syk/IRAK1-targeted anti-inflammatory action of Torreya nucifera butanol fraction in lipopolysaccharide-activated RAW264.7 cells. J Ethnopharmacol 188, 167–176, 2016. doi:10.1016/j.jep.2016.05.008.
   PubMed Web of Science ®Google Scholar
• Jones DJL, Lamb JH, Verschoyle RD, Howells LM, Butterworth M, et al.: Characterisation of metabolites of the putative cancer chemopreventive agent quercetin and their effect on cyclo-oxygenase activity. Br J Cancer 91, 1213–1219, 2004. doi:10.1038/sj.bjc.6602091.
   PubMed Web of Science ®Google Scholar
• Lai WW, Hsu SC, Chueh FS, Chen YY, Yang JS, et al.: Quercetin inhibits migration and invasion of SAS human oral cancer cells through inhibition of NF-kappa B and matrix metalloproteinase-2/-9 signaling pathways. Anticancer Res 33, 1941–1950, 2013.
   PubMed Web of Science ®Google Scholar
• Senthilkumar K, Arunkumar R, Elumalai P, Sharmila G, Gunadharini DN, et al.: Quercetin inhibits invasion, migration and signalling molecules involved in cell survival and proliferation of prostate cancer cell line (PC-3). Cell Biochem Funct 29, 87–95, 2011. doi:10.1002/cbf.1725.
   PubMed Web of Science ®Google Scholar
• Cheong E, Ivory K, Doleman J, Parker ML, Rhodes M, et al.: Synthetic and naturally occurring COX-2 inhibitors suppress proliferation in a human oesophageal adenocarcinoma cell line (OE33) by inducing apoptosis and cell cycle arrest. Carcinogenesis 25, 1945–1952, 2004. doi:10.1093/carcin/bgh184.
   PubMed Web of Science ®Google Scholar
• Xiao XS, Shi DB, Liu LQ, Wang JS, Xie XM, et al.: Quercetin suppresses cyclooxygenase-2 expression and angiogenesis through inactivation of P300 signaling. Plos One 6, e22934, 2011. doi:10.1371/journal.pone.0022934.
   PubMed Web of Science ®Google Scholar
• Maurya AK and Vinayak M: Anticarcinogenic action of quercetin by downregulation of phosphatidylinositol 3-kinase (PI3K) and protein kinase C (PKC) via induction of p53 in hepatocellular carcinoma (HepG2) cell line. Mol Biol Rep 42, 1419–1429, 2015. doi:10.1007/s11033-015-3921-7.
   PubMed Web of Science ®Google Scholar
• Lee KM, Hwang MK, Lee DE, Lee KW, and Lee HJ: Protective effect of quercetin against arsenite-induced COX-2 expression by targeting PI3K in rat liver epithelial cells. J Agric Food Chem 58, 5815–5820, 2010. doi:10.1021/jf903698s.
   PubMed Web of Science ®Google Scholar
• Zhu X, Zeng X, Zhang X, Cao W, Wang Y, et al.: The effects of quercetin-loaded PLGA-TPGS nanoparticles on ultraviolet B-induced skin damages in vivo. Nanomedicine 12, 623–632, 2016. doi:10.1016/j.nano.2015.10.016.
   PubMed Web of Science ®Google Scholar
• Lee YK, Park SY, Kim YM, Lee WS, and Park OJ: AMP kinase/cyclooxygenase-2 pathway regulates proliferation and apoptosis of cancer cells treated with quercetin. Exp Mol Med 41, 201–207, 2009. doi:10.3858/emm.2009.41.3.023.
   PubMed Web of Science ®Google Scholar
• Lau TY and Leung LK: Soya isoflavones suppress phorbol 12-myristate 13-acetate-induced COX-2 expression in MCF-7 cells. Br J Nutr 96, 169–176, 2006. doi:10.1079/Bjn20061639.
   PubMed Web of Science ®Google Scholar
• Shon YH, Park SD, and Nam KS: Effective chemopreventive activity of genistein against human breast cancer cells. J Biochem Mol Biol 39, 448–451, 2006.
   PubMedGoogle Scholar
• Chung MH, Kim DH, Na HK, Kim JH, Kim HN, et al.: Genistein inhibits phorbol ester-induced NF-kappaB transcriptional activity and COX-2 expression by blocking the phosphorylation of p65/RelA in human mammary epithelial cells. Mutat Res 768, 74–83, 2014. doi:10.1016/j.mrfmmm.2014.04.003.
   PubMed Web of Science ®Google Scholar
• Li YS, Wu LP, Li KH, Liu YP, Xiang R, et al.: Involvement of nuclear factor kappaB (NF-kappaB) in the downregulation of cyclooxygenase-2 (COX-2) by genistein in gastric cancer cells. J Int Med Res 39, 2141–2150, 2011.
   PubMed Web of Science ®Google Scholar
• Dai W, Wang F, He L, Lin C, Wu S, et al.: Genistein inhibits hepatocellular carcinoma cell migration by reversing the epithelial-mesenchymal transition: partial mediation by the transcription factor NFAT1. Mol Carcinog 54, 301–311, 2015. doi:10.1002/mc.22100.
   PubMed Web of Science ®Google Scholar
• Sarkar D, Saha P, Gamre S, Bhattacharjee S, Hariharan C, et al.: Anti-inflammatory effect of allylpyrocatechol in LPS-induced macrophages is mediated by suppression of iNOS and COX-2 via the NF-kappa B pathway. Int Immunopharmacol 8, 1264–1271, 2008. doi:10.1016/j.intimp.2008.05.003.
   PubMed Web of Science ®Google Scholar
• Hwang JT, Ha J, and Park OJ: Combination of 5-fluorouracil and genistein induces apoptosis synergistically in chemo-resistant cancer cells through the modulation of AMPK and COX-2 signaling pathways. Biochem Biophys Res Commun 332, 433–440, 2005. doi:10.1016/j.bbrc.2005.04.143.
   PubMed Web of Science ®Google Scholar
• Zhou JM and Ibrahim RK: Tricin-a potential multifunctional nutraceutical. Phytochem Rev 9, 413–424, 2010. doi:10.1007/s11101-009-9161-5.
   Web of Science ®Google Scholar
• Hudson EA, Dinh PA, Kokubun T, Simmonds MSJ, and Gescher A: Characterization of potentially chemopreventive phenols in extracts of brown rice that inhibit the growth of human breast and colon cancer cells. Cancer Epidemiol Biomarkers Prev 9, 1163–1170, 2000.
   PubMed Web of Science ®Google Scholar
• Cai H, Al-Fayez M, Tunstall RG, Platton S, Greaves P, et al.: The rice bran constituent tricin potently inhibits cyclooxygenase enzymes and interferes with intestinal carcinogenesis in ApcMin mice. Mol Cancer Ther 4, 1287–1292, 2005. doi:10.1158/1535-7163.MCT-05-0165.
   PubMed Web of Science ®Google Scholar
• Kim KM, Kim YS, Lim JY, Min SJ, Ko HC, et al.: Intestinal anti-inflammatory activity of Sasa quelpaertensis leaf extract by suppressing lipopolysaccharide-stimulated inflammatory mediators in intestinal epithelial Caco-2 cells co-cultured with RAW 264.7 macrophage cells. Nutr Res Pract 9, 3–10, 2015. doi:10.4162/nrp.2015.9.1.3.
   PubMed Web of Science ®Google Scholar
• Shalini V, Pushpan CK, Sindhu G, Jayalekshmy A, and Helen A: Tricin, flavonoid from Njavara reduces inflammatory responses in hPBMCs by modulating the p38MAPK and PI3K/Akt pathways and prevents inflammation associated endothelial dysfunction in HUVECs. Immunobiology 221, 137–144, 2016. doi:10.1016/j.imbio.2015.09.016
   PubMed Web of Science ®Google Scholar
• Shalini V, Jayalekshmi A, and Helen A: Mechanism of anti-inflammatory effect of tricin, a flavonoid isolated from Njavara rice bran in LPS induced hPBMCs and carrageenan induced rats. Mol Immunol 66, 229–239, 2015. doi:10.1016/j.molimm.2015.03.004.
   PubMed Web of Science ®Google Scholar
• Willenberg I, Meschede AK, Gueler F, Jang MS, Shushakova N, et al.: Food polyphenols fail to cause a biologically relevant reduction of COX-2 activity. Plos One 10, e0139147, 2015. doi:10.1371/journal.pone.0139147.
   PubMed Web of Science ®Google Scholar
• Calder PC: Long-chain n-3 fatty acids and inflammation: potential application in surgical and trauma patients. Braz J Med Biol Res 36, 433–446, 2003.
   PubMed Web of Science ®Google Scholar
• Calder PC: Long-chain fatty acids and inflammation. Proc Nutr Soc 71, 284–289, 2012. doi:10.1017/S0029665112000067.
   PubMed Web of Science ®Google Scholar
• Lee JY, Sohn KH, Rhee SH, and Hwang D: Saturated fatty acids, but not unsaturated fatty acids, induce the expression of cyclooxygenase-2 mediated through Toll-like receptor 4. J Biol Chem 276, 16683–16689, 2001. doi:10.1074/jbc.M011695200.
   PubMed Web of Science ®Google Scholar
• Han YM, Jeong M, Park JM, Kim MY, Go EJ, et al.: The omega-3 polyunsaturated fatty acids prevented colitis-associated carcinogenesis through blocking dissociation of beta-catenin complex, inhibiting COX-2 through repressing NF-kappaB, and inducing 15-prostaglandin dehydrogenase. Oncotarget 7, 63583–63595, 2016. doi:10.18632/oncotarget.11544.
   PubMedGoogle Scholar
• Vara-Messler M, Buccellati C, Pustina L, Folco G, Rovati GE, et al.: A potential role of PUFAs and COXIBs in cancer chemoprevention. Prostaglandins Other Lipid Mediat 120, 97–102, 2015. doi:10.1016/j.prostaglandins.2015.04.003.
   PubMed Web of Science ®Google Scholar
• Camuesco D, Comalada M, Concha A, Nieto A, Sierra S, et al.: Intestinal anti-inflammatory activity of combined quercitrin and dietary olive oil supplemented with fish oil, rich in EPA and DHA (n-3) polyunsaturated fatty acids, in rats with DSS-induced colitis. Clin Nutr 25, 466–476, 2006. doi:10.1016/j.clnu.2005.12.009.
   PubMed Web of Science ®Google Scholar
• Camuesco D, Galvez J, Nieto A, Comalada M, Rodriguez-Cabezas ME, et al.: Dietary olive oil supplemented with fish oil, rich in EPA and DHA (n-3) polyunsaturated fatty acids, attenuates colonic inflammation in rats with DSS-induced colitis. J Nutr 135, 687–694, 2005. doi: 135/4/687 [pii].
   PubMed Web of Science ®Google Scholar
• Zhang C, Yu H, Ni X, Shen S, and Das UN: Growth inhibitory effect of polyunsaturated fatty acids (PUFAs) on colon cancer cells via their growth inhibitory metabolites and fatty acid composition changes. PLoS One 10, e0123256, 2015. doi:10.1371/journal.pone.0123256.
   PubMed Web of Science ®Google Scholar
• Fini L, Piazzi G, Ceccarelli C, Daoud Y, Belluzzi A, et al.: Highly purified eicosapentaenoic acid as free fatty acids strongly suppresses polyps in Apc(Min/+) mice. Clin Cancer Res 16, 5703–5711, 2010. doi:10.1158/1078-0432.Ccr-10-1990.
   PubMed Web of Science ®Google Scholar
• Fradet V, Cheng I, Casey G, and Witte JS: Dietary omega-3 fatty acids, cyclooxygenase-2 genetic variation, and aggressive prostate cancer risk. Clin Cancer Res 15, 2559–2566, 2009. doi:10.1158/1078-0432.CCR-08-2503.
   PubMed Web of Science ®Google Scholar
• Vara-Messler M, Pasqualini ME, Comba A, Silva R, Buccellati C, et al.: Increased dietary levels of alpha-linoleic acid inhibit mammary tumor growth and metastasis. Eur J Nutr 56, 509–519, 2017. doi:10.1007/s00394-015-1096-6.
   PubMed Web of Science ®Google Scholar
• Vecchini A, Ceccarelli V, Susta F, Caligiana P, Orvietani P, et al.: Dietary alpha-linolenic acid reduces COX-2 expression and induces apoptosis of hepatoma cells. J Lipid Res 45, 308–316, 2004. doi:10.1194/jlr.M300396-JLR200.
   PubMed Web of Science ®Google Scholar
• Schiessel DL, Yamazaki RK, Kryczyk M, Coelho I, Yamaguchi AA, et al.: Alpha-linolenic fatty acid supplementation decreases tumor growth and cachexia parameters in walker 256 tumor-bearing rats. Nutr Cancer 67, 839–846, 2015. doi:10.1080/01635581.2015.1043021.
   PubMed Web of Science ®Google Scholar
• Gullett NP, Ruhul Amin AR, Bayraktar S, Pezzuto JM, Shin DM, et al.: Cancer prevention with natural compounds. Semin Oncol 37, 258–281, 2010. doi:10.1053/j.seminoncol.2010.06.014.
   PubMed Web of Science ®Google Scholar
• Mencher SK and Wang LG: Promiscuous drugs compared to selective drugs (promiscuity can be a virtue). BMC Clin Pharmacol 5, 3, 2005. doi:10.1186/1472-6904-5-3.
   PubMedGoogle Scholar
• Riboli E and Norat T: Epidemiologic evidence of the protective effect of fruit and vegetables on cancer risk. Am J Clin Nutr 78, 559S–569S, 2003.
   PubMed Web of Science ®Google Scholar
• Eikenberry N and Smith C: Healthful eating: perceptions, motivations, barriers, and promoters in low-income Minnesota communities. J Am Diet Assoc 104, 1158–1161, 2004. doi:10.1016/j.jada.2004.04.023.
   PubMed Web of Science ®Google Scholar
• Cox BD, Whichelow MJ, and Prevost AT: Seasonal consumption of salad vegetables and fresh fruit in relation to the development of cardiovascular disease and cancer. Public Health Nutr 3, 19–29, 2000.
   PubMed Web of Science ®Google Scholar
• van't Veer P, Jansen MC, Klerk M, and Kok FJ: Fruits and vegetables in the prevention of cancer and cardiovascular disease. Public Health Nutr 3, 103–107, 2000.
   PubMed Web of Science ®Google Scholar
• Bingham SA, Day NE, Luben R, Ferrari P, Slimani N, et al.: Dietary fibre in food and protection against colorectal cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC): an observational study. Lancet 361, 1496–1501, 2003. doi:10.1016/S0140-6736(03)13174-1.
   PubMed Web of Science ®Google Scholar
• Sandoval M, Font R, Manos M, Dicenta M, Quintana MJ, et al.: The role of vegetable and fruit consumption on survival and other habits following the diagnosis of oral cancer: a prospective study in Spain. Int J Oral Maxillofacial Surg 38, 31–39, 2009. doi:10.1016/j.ijom.2008.09.004.
   PubMed Web of Science ®Google Scholar
• Pavia M, Pileggi C, Nobile CGA, and Angelillo IF: Association between fruit and vegetable consumption and oral cancer: a meta-analysis of observational studies. Am J Clin Nutr 83, 1126–1134, 2006.
   PubMed Web of Science ®Google Scholar
• Michels KB, Giovannucci E, Chan AT, Singhania R, Fuchs CS, et al.: Fruit and vegetable consumption and colorectal adenomas in the nurses' health study. Cancer Res 66, 3942–3953, 2006. doi:10.1158/0008-5472.Can-05-3637.
   PubMed Web of Science ®Google Scholar
• Malongane F, McGaw LJ, and Mudau FN: The synergistic potential of various teas, herbs and therapeutic drugs in health improvement: a review. J Sci Food Agric 97, 4679–4689, 2017.
   PubMed Web of Science ®Google Scholar